Biocon

{
  "main_header": {
    "sid": 201791,
    "name": "Biocon",
    "stock_name": "Biocon",
    "full_name": "Biocon Ltd.",
    "name_url": "stocks-analysis/biocon",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "390.45",
    "chg": 10.05,
    "chgp": "2.64%",
    "dir": 1,
    "prev_price": "380.40",
    "mcapval": "62,008.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532523,
    "symbol": "BIOCON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE376G01013",
    "curr_date": "May 11",
    "curr_time": "",
    "bse_nse_vol": "1.35 cr",
    "exc_status": "Active",
    "traded_date": "May 11, 2026",
    "traded_date_str": "2026 05 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "HT",
      "url": "https://www.marketsmojo.com/mojopro/strategy/1",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Biocon Ltd Gains 5.59%: 4 Key Factors Driving This Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-gains-559-4-key-factors-driving-this-weeks-momentum-3984253",
        "imagepath": "",
        "date": "2026-05-10 14:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Technical momentum signals bearish outlook amid mixed market returns</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts to mildly bearish with mixed signals</p>\n                    <p><strong>8 May:</strong> Surge in call option activity signals bullish momentum</p>\n                    <p><strong>8 May:</strong> Q4 FY26 results reveal profit recovery but persistent margin weakness</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.360.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">..."
      },
      {
        "title": "Are Biocon Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-biocon-ltd-latest-results-good-or-bad-3983744",
        "imagepath": "",
        "date": "2026-05-09 19:15:05",
        "description": "Biocon Ltd.'s latest financial results for Q4 FY26 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹4,516.60 crores, achieving an 8.23% sequential growth and a 2.25% increase year-on-year. This marks the highest quarterly revenue in the company's history, indicating a positive trend in top-line performance.\n\nHowever, the net profit for the same quarter was ₹125.90 crores, reflecting a significant year-on-year decline of 63.45% from ₹344.50 crores in Q4 FY25. This sharp drop in profitability, alongside a sequential decrease of 12.45% from the previous quarter, highlights substantial operational challenges. The operating margin stood at 22.75%, which is down 199 basis points from the prior year, signaling increasing cost pressures that have impacted the company's ability to convert revenue growth into profit.\n\nFor the f..."
      },
      {
        "title": "Biocon Q4 FY26: Profit Recovery Masks Persistent Margin Weakness",
        "link": "https://www.marketsmojo.com/news/result-analysis/biocon-q4-fy26-profit-recovery-masks-persistent-margin-weakness-3982301",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/Biocon_quaterlyResult_3982301.png",
        "date": "2026-05-08 17:45:38",
        "description": "Biocon Ltd., India's largest integrated biopharmaceutical company, reported consolidated net profit of ₹125.90 crores for Q4 FY26 (Mar'26 quarter), marking a sharp decline of 63.45% year-on-year from ₹344.50 crores in the corresponding quarter last year. On a sequential basis, profit fell 12.45% from ₹143.80 crores in Q3 FY26 (Dec'25). The company's stock, trading at ₹380.55 with a market capitalisation of ₹63,183 crores, has declined 0.54% following the results announcement, reflecting investor concerns about profitability compression despite revenue growth."
      },
      {
        "title": "Rs 400 Calls on Biocon Ltd. See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-surge-in-call-option-activity-amid-bullish-momentum-3981251",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_most_active_stocks_calls_3981251.png",
        "date": "2026-05-08 10:00:08",
        "description": "4,796 call contracts at the Rs 400 strike traded on Biocon Ltd. on 8 May 2026, with the stock closing at Rs 389.30 after a 1.71% gain. This near-the-money activity coincides with a five-day rally that has lifted the share price by 8.88%, signalling a synchronised directional conviction in both the cash and derivatives markets."
      },
      {
        "title": "Biocon Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-sell-by-marketsmojo-3977507",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_mojoScore_3977507.png",
        "date": "2026-05-06 10:10:40",
        "description": "Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Biocon Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-amid-mixed-market-signals-3974601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_technicaldot_3974601.png",
        "date": "2026-05-05 08:00:43",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day change of 0.24% to close at ₹360.40, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential stabilisation. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market."
      },
      {
        "title": "Biocon Ltd. Technical Momentum Shifts Signal Bearish Outlook Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-signal-bearish-outlook-amid-mixed-market-returns-3973393",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_technicaldot_3973393.png",
        "date": "2026-05-04 08:00:17",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, which collectively signal a cautious outlook for investors amid mixed signals and recent price movements."
      },
      {
        "title": "Biocon Ltd Gains 2.83%: Key Technical and Derivatives Activity Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-gains-283-key-technical-and-derivatives-activity-shape-week-3971934",
        "imagepath": "",
        "date": "2026-05-03 14:00:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Stock surged 3.47% on strong volume and Sensex gains</p>\n                    <p><strong>29 Apr:</strong> Sharp 36.05% rise in derivatives open interest amid mixed technical signals</p>\n                    <p><strong>30 Apr:</strong> Price slipped 0.76% as technical momentum showed mild bearishness</p>\n                    <p><strong>01 May:</strong> No trading data available; week closed at Rs.359.55</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.349.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week C..."
      },
      {
        "title": "Biocon Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-surge-in-derivatives-open-interest-amid-mixed-market-signals-3968498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BioconLtd_oi_spurts_by_underlying_3968498.png",
        "date": "2026-04-29 15:00:07",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 36.05% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price gain of 0.14% on 29 Apr 2026, the stock underperformed its sector by 0.36% and the broader Sensex by 0.81%, reflecting a complex interplay between bullish bets and cautious sentiment."
      }
    ],
    "total": 5821,
    "sid": "201791",
    "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791"
  },
  "announcements": [
    {
      "details": "Biocon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Biocon Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Biocon Limited has informed the Exchange regarding a press release dated December 02, 2019, titled \"Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri (trastuzumab-dkst), in the U.S.\".",
      "source": "NSE",
      "caption": "Biocon Limited - Press Release",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Biocon Limited has informed the Exchange regarding a press release dated November 27, 2019, titled \"",
      "source": "NSE",
      "caption": "Biocon Limited - Press Release",
      "datetime": "27-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 04 Jul 25",
          "dt": "2025-07-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19",
          "dt": "2019-06-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biocon Ltd Gains 5.59%: 4 Key Factors Driving This Week’s Momentum

2026-05-10 14:00:05

Key Events This Week

4 May: Technical momentum signals bearish outlook amid mixed market returns

5 May: Technical momentum shifts to mildly bearish with mixed signals

8 May: Surge in call option activity signals bullish momentum

8 May: Q4 FY26 results reveal profit recovery but persistent margin weakness

Week Open

Rs.360.40

...

Read full news article

Are Biocon Ltd. latest results good or bad?

2026-05-09 19:15:05

Biocon Ltd.'s latest financial results for Q4 FY26 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹4,516.60 crores, achieving an 8.23% sequential growth and a 2.25% increase year-on-year. This marks the highest quarterly revenue in the company's history, indicating a positive trend in top-line performance. However, the net profit for the same quarter was ₹125.90 crores, reflecting a significant year-on-year decline of 63.45% from ₹344.50 crores in Q4 FY25. This sharp drop in profitability, alongside a sequential decrease of 12.45% from the previous quarter, highlights substantial operational challenges. The operating margin stood at 22.75%, which is down 199 basis points from the prior year, signaling increasing cost pressures that have impacted the company's ability to convert revenue growth into profit. For the f...

Read full news article

Biocon Q4 FY26: Profit Recovery Masks Persistent Margin Weakness

2026-05-08 17:45:38

Biocon Ltd., India's largest integrated biopharmaceutical company, reported consolidated net profit of ₹125.90 crores for Q4 FY26 (Mar'26 quarter), marking a sharp decline of 63.45% year-on-year from ₹344.50 crores in the corresponding quarter last year. On a sequential basis, profit fell 12.45% from ₹143.80 crores in Q3 FY26 (Dec'25). The company's stock, trading at ₹380.55 with a market capitalisation of ₹63,183 crores, has declined 0.54% following the results announcement, reflecting investor concerns about profitability compression despite revenue growth.

Read full news article

Rs 400 Calls on Biocon Ltd. See Heavy Activity — What the Strike Price Tells You

2026-05-08 10:00:08

4,796 call contracts at the Rs 400 strike traded on Biocon Ltd. on 8 May 2026, with the stock closing at Rs 389.30 after a 1.71% gain. This near-the-money activity coincides with a five-day rally that has lifted the share price by 8.88%, signalling a synchronised directional conviction in both the cash and derivatives markets.

Read full news article

Biocon Ltd. is Rated Sell by MarketsMOJO

2026-05-06 10:10:40

Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Biocon Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-05-05 08:00:43

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day change of 0.24% to close at ₹360.40, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential stabilisation. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market.

Read full news article

Biocon Ltd. Technical Momentum Shifts Signal Bearish Outlook Amid Mixed Market Returns

2026-05-04 08:00:17

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, which collectively signal a cautious outlook for investors amid mixed signals and recent price movements.

Read full news article

Biocon Ltd Gains 2.83%: Key Technical and Derivatives Activity Shape Week

2026-05-03 14:00:03

Key Events This Week

27 Apr: Stock surged 3.47% on strong volume and Sensex gains

29 Apr: Sharp 36.05% rise in derivatives open interest amid mixed technical signals

30 Apr: Price slipped 0.76% as technical momentum showed mild bearishness

01 May: No trading data available; week closed at Rs.359.55

Week Open

Rs.349.65

Week C...

Read full news article

Biocon Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Mixed Market Signals

2026-04-29 15:00:07

Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 36.05% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price gain of 0.14% on 29 Apr 2026, the stock underperformed its sector by 0.36% and the broader Sensex by 0.81%, reflecting a complex interplay between bullish bets and cautious sentiment.

Read full news article

View All News